BSH 2017: Are we ready to use minimum residual disease to direct therapy?
Studies show that MM patients who achieve minimal residual disease on treatment have longer PFS and OS than those who do not…
Subscribe for our mailing list
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.